What This Document Is
This document is a clinical protocol developed for Chamberlain University’s Advanced Pharmacology Fundamentals (NR 565) course, specifically addressing the initial assessment and management of hypertension (HTN) and hyperlipidemia. It’s designed to guide advanced practice nursing students through a systematic approach to differentiating between primary hypertension and hypertension potentially caused by renal artery stenosis, and to initiate appropriate lipid management.
Why This Document Matters
This protocol is crucial for advanced practice nursing students preparing to independently manage patients with common cardiovascular risk factors. It provides a framework for a focused history, physical exam, and laboratory evaluation to identify patients who may require specialist referral (nephrology) and to initiate evidence-based pharmacological treatment. It’s intended for use during clinical rotations and will be relevant for any nurse practitioner managing adult patients in primary care or cardiology settings. The protocol emphasizes a proactive approach to preventing renal damage and optimizing cardiovascular health.
Common Limitations or Challenges
This protocol focuses on the *initial* patient encounter. It does not cover ongoing management, complex cases, or detailed dosage adjustments. It also serves as a guide and requires clinical judgment and consideration of individual patient factors not explicitly addressed within the protocol. It is not a substitute for comprehensive pharmacology knowledge or clinical supervision.
What This Document Provides
The full document includes: a rationale for the protocol’s focus on renal artery stenosis; detailed symptom checklists for hypertension and renal artery stenosis; a focused history and physical exam guide, including specific findings that warrant consultation with a supervising physician; a list of recommended initial laboratory tests (metabolic panel, GFR); and a starting point for pharmacological treatment of hypertension, listing drug classifications (thiazide diuretics, ACE inhibitors, calcium channel blockers) with generic examples. It also includes a specific example of initiating treatment with Lisinopril, including estimated cost and patient education points. The document cites relevant clinical practice guidelines (James et al., 2014; Rosenthal & Burchum, 2021). This preview does *not* include specific dosage recommendations, detailed patient education materials beyond a brief example, or a comprehensive discussion of all possible comorbidities.